OTC Pravachol Use Among Rx Patients Needs More Study, FDA Cmte. Says

The reason individuals switch from taking prescription cholesterol-lowering agents to OTC Pravachol (pravastatin) in actual use studies should be the subject of additional research, FDA advisory committee members suggested to Bristol-Myers Squibb July 14.